1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid

C111H111BBr2Ir2N16O2-8 — CID 162068441

IUPAC1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid
SMILESCC(C)(C)c1cnc2c(n1)N(c1[c-]ccc(Br)c1)[CH-]N2c1ccccc1.CC(C)(C)c1cnc2c(n1)N(c1ccccc1)[CH-]N2c1[c-]ccc(Br)c1.CC(C)c1ccccc1-c1cc[c-]c(N2[CH-]N(c3ccccc3)c3nc(C(C)(C)C)cnc32)c1.CC(C)c1ccccc1-c1cc[c-]c(N2[CH-]N(c3ccccc3)c3ncc(C(C)(C)C)nc32)c1.CC(C)c1ccccc1B(O)O.[Ir].[Ir]
InChIInChI=1S/2C30H30N4.2C21H19BrN4.C9H13BO2.2Ir/c1-21(2)25-16-9-10-17-26(25)22-12-11-15-24(18-22)34-20-33(23-13-7-6-8-14-23)29-28(34)31-19-27(32-29)30(3,4)5;1-21(2)25-16-9-10-17-26(25)22-12-11-15-24(18-22)34-20-33(23-13-7-6-8-14-23)28-29(34)32-27(19-31-28)30(3,4)5;1-21(2,3)18-13-23-19-20(24-18)25(16-9-5-4-6-10-16)14-26(19)17-11-7-8-15(22)12-17;1-21(2,3)18-13-23-19-20(24-18)26(17-11-7-8-15(22)12-17)14-25(19)16-9-5-4-6-10-16;1-7(2)8-5-3-4-6-9(8)10(11)12;;/h2*6-14,16-21H,1-5H3;2*4-10,12-14H,1-3H3;3-7,11-12H,1-2H3;;/q4*-2;;;
InChIKeyZUCADGXUPMNZKK-UHFFFAOYSA-N
MW2256.27 g/mol
LogP27.52
Rot. Bonds14

About 1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid

1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid (PubChem CID 162068441) has the molecular formula C111H111BBr2Ir2N16O2-8 and a molecular weight of 2256.27 g/mol. Its IUPAC name is 1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid.

Molecular Properties

Compound Name1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid
PubChem CID162068441
Molecular FormulaC111H111BBr2Ir2N16O2-8
Molecular Weight2256.27 g/mol
Exact Mass2254.68
IUPAC Name1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid
SMILESCC(C)(C)c1cnc2c(n1)N(c1[c-]ccc(Br)c1)[CH-]N2c1ccccc1.CC(C)(C)c1cnc2c(n1)N(c1ccccc1)[CH-]N2c1[c-]ccc(Br)c1.CC(C)c1ccccc1-c1cc[c-]c(N2[CH-]N(c3ccccc3)c3nc(C(C)(C)C)cnc32)c1.CC(C)c1ccccc1-c1cc[c-]c(N2[CH-]N(c3ccccc3)c3ncc(C(C)(C)C)nc32)c1.CC(C)c1ccccc1B(O)O.[Ir].[Ir]
InChIInChI=1S/2C30H30N4.2C21H19BrN4.C9H13BO2.2Ir/c1-21(2)25-16-9-10-17-26(25)22-12-11-15-24(18-22)34-20-33(23-13-7-6-8-14-23)29-28(34)31-19-27(32-29)30(3,4)5;1-21(2)25-16-9-10-17-26(25)22-12-11-15-24(18-22)34-20-33(23-13-7-6-8-14-23)28-29(34)32-27(19-31-28)30(3,4)5;1-21(2,3)18-13-23-19-20(24-18)25(16-9-5-4-6-10-16)14-26(19)17-11-7-8-15(22)12-17;1-21(2,3)18-13-23-19-20(24-18)26(17-11-7-8-15(22)12-17)14-25(19)16-9-5-4-6-10-16;1-7(2)8-5-3-4-6-9(8)10(11)12;;/h2*6-14,16-21H,1-5H3;2*4-10,12-14H,1-3H3;3-7,11-12H,1-2H3;;/q4*-2;;;
InChIKeyZUCADGXUPMNZKK-UHFFFAOYSA-N
XLogP27.52
TPSA169.50 Ų
H-Bond Donors2
H-Bond Acceptors18
Rotatable Bonds14
Heavy Atoms134
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002256.27
LogP ≤ 527.52
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid?
The IUPAC name of 1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid (CID 162068441) is 1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid.
What is the SMILES notation for 1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid?
The canonical SMILES for 1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid is CC(C)(C)c1cnc2c(n1)N(c1[c-]ccc(Br)c1)[CH-]N2c1ccccc1.CC(C)(C)c1cnc2c(n1)N(c1ccccc1)[CH-]N2c1[c-]ccc(Br)c1.CC(C)c1ccccc1-c1cc[c-]c(N2[CH-]N(c3ccccc3)c3nc(C(C)(C)C)cnc32)c1.CC(C)c1ccccc1-c1cc[c-]c(N2[CH-]N(c3ccccc3)c3ncc(C(C)(C)C)nc32)c1.CC(C)c1ccccc1B(O)O.[Ir].[Ir].
What is the InChIKey of 1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid?
The InChIKey is ZUCADGXUPMNZKK-UHFFFAOYSA-N. The full InChI is InChI=1S/2C30H30N4.2C21H19BrN4.C9H13BO2.2Ir/c1-21(2)25-16-9-10-17-26(25)22-12-11-15-24(18-22)34-20-33(23-13-7-6-8-14-23)29-28(34)31-19-27(32-29)30(3,4)5;1-21(2)25-16-9-10-17-26(25)22-12-11-15-24(18-22)34-20-33(23-13-7-6-8-14-23)28-29(34)32-27(19-31-28)30(3,4)5;1-21(2,3)18-13-23-19-20(24-18)25(16-9-5-4-6-10-16)14-26(19)17-11-7-8-15(22)12-17;1-21(2,3)18-13-23-19-20(24-18)26(17-11-7-8-15(22)12-17)14-25(19)16-9-5-4-6-10-16;1-7(2)8-5-3-4-6-9(8)10(11)12;;/h2*6-14,16-21H,1-5H3;2*4-10,12-14H,1-3H3;3-7,11-12H,1-2H3;;/q4*-2;;;.
What are the key properties of 1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid?
1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid has a molecular weight of 2256.27 g/mol, XLogP of 27.52, 14 rotatable bonds, 2 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(3-bromobenzene-6-id-1-yl)-5-tert-butyl-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-1-phenyl-3-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;5-tert-butyl-3-phenyl-1-[3-(2-propan-2-ylphenyl)benzene-6-id-1-yl]-2H-imidazo[4,5-b]pyrazin-2-ide;bis(iridium);(2-propan-2-ylphenyl)boronic acid is sourced from PubChem (CID 162068441), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).